Advertising America China Chinese Currency Cybersecurity Dollar Economy Europe European Healthcare Investment Italy Manila Medicine Middle East Patent Pharmaceutical Philippines Revenue Russia Technology Turkey Ukraine United States
FLORENCE, Italy, March 09, 2026 (GLOBE NEWSWIRE) — 2025 was a “positive year” for Menarini, which is celebrating its 140th anniversary this year, despite considerable global “turbulence”. Lucia Aleotti, shareholder and member of the Menarini Board, said so with a smile as she opened the company’s customary annual meeting at the Florence Chamber of Commerce, starting with the figures. The pharmaceutical group, which operates in 140 countries worldwide, reported revenue “approaching €4.9 billion” – €4.887 billion to be precise – marking a 6.2% increase compared with 2024, with “EBITDA estimated between €440 million and €470 million”. The strength of women…
News Timeline:
Track the development of this news story across the Internet.